September 21, 2014 1:14 PM ET

Capital Markets

Company Overview of OrbiMed Advisors, L.L.C.

Company Overview

OrbiMed Advisors, L.L.C. is a private equity and venture capital firm specializing in startups and growth capital investments. It primarily provides its services to pooled investment vehicles. It also caters to investment companies. The firm manages mutual, hedge, royalty and debt funds, venture capital, public and private equity funds for its clients. It primarily invests in the public equity and hedging markets across the globe. The firm primarily invests in healthcare, global health science industry including pharmaceutical, life science, healthcare services, biotechnology, biopharmaceuticals, diagnostics, health IT, and medical device companies. It seeks to invest globally, including Ind...

601 Lexington Avenue at 53rd Street

54th Floor

New York, NY 10022-4629

United States

Founded in 1989





Key Executives for OrbiMed Advisors, L.L.C.

Age: 69
Founding General Partner
Age: 63
Founding General Partner
Age: 49
Founding General Partner
Age: 46
General Partner
Age: 47
Compensation as of Fiscal Year 2014.

OrbiMed Advisors, L.L.C. Key Developments

OrbiMed Advisors, L.L.C. Presents at AVCJ 9th Annual Private Equity & Venture Forum USA 2014, Jul-08-2014 04:00 PM

OrbiMed Advisors, L.L.C. Presents at AVCJ 9th Annual Private Equity & Venture Forum USA 2014, Jul-08-2014 04:00 PM. Venue: Harvard Club of New York City, 35 West 44th Street, New York, NY 10036, United States. Speakers: Sunny Sharma, Senior Managing Director of Asia.

Carlyle Reportedly In Talks With Bharat Serums

The Carlyle Group LP (NasdaqGS:CG) is in talks with Bharat Serums and Vaccines Limited. Carlyle in negotiating with Bharat Serums to buy a significant minority stake in the latter from existing investors for INR 5 billion-INR 6 billion. The company is in discussion to buy the 15% stake held by Kotak Mahindra Bank Limited’s (BSE:500247) private equity arm as well as another 8%-10% held by OrbiMed Advisors, L.L.C. According to sources close to the matter, Carlyle is likely to buy about 25%-30% stake in Bharat Serums. The report mentioned that it is not clear whether the promoters will dilute their stake in this round of fundraising. The news report mentioned that a Carlyle spokesperson said, “As company policy, Carlyle does not comment on market speculation,” while mails to Gautam Daftary, Vice-Chairman and Managing Director of Bharat Serums, and Deshmukh of Kotak Investment Advisors Limited went unanswered.

OrbiMed Advisors, L.L.C. Presents at Boston CEO Conference, Jun-04-2014 04:30 PM

OrbiMed Advisors, L.L.C. Presents at Boston CEO Conference, Jun-04-2014 04:30 PM. Venue: Four Seasons Hotel, 200 Boylston Street, Boston, MA 02116, Massachusetts, United States. Speakers: Carl L. Gordon, Founding General Partner, Partner, and Co-Head of Private Equity.

Similar Private Companies By Industry

Company Name Region
Luminary Acquisition Corp. United States
M&A Securities Group, Inc United States
KCI Investing United States
Phoenix India Acquisition Corp. United States
BBVA Securities Inc., Research Division United States

Recent Private Companies Transactions

Private Placement
September 2, 2014
Affimed Therapeutics B.V.
Private Placement
August 28, 2014
GC-Rise Pharmaceutical Co., Ltd.
August 24, 2014
InterMune, Inc.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OrbiMed Advisors, L.L.C., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at